Rejuvenon (The Woodlands, Texas) raised $37 million in a series B round led by Schroder Ventures Life Sciences. Rejuvenon in-licenses and develops small molecules to treat cancer and metabolic diseases. The company's RC1291 ghrelin mimetic...

Peter Stadler, head of technical operations biotechnology at Bayer AG , is warning Europe's venture capitalists and institutions to tread carefully when they look to invest in European biotech. Having successfully raised huge sums of...

Baylor researchers reported in the latest Proceedings of the National Academy of Sciences that they have developed two peptides 29 amino acids long, one of which, ChPepz, mimics the active site of alpha-chymotrypsin. The other,...